Browse
Explore conditions, clinical trials, and the organisations running them.
Never miss a new study
Get alerted when new trials match your condition
Sign up free to track the conditions you care about and get a personal digest when new trials appear.
By submitting, you agree to our Terms of use
116076 trials found · Page 1576 of 5804
-
New drug combo aims to outsmart High-Risk leukemia
Disease control Recruiting nowThis phase I trial identifies the best dose and clinical benefit of giving pemigatinib following standard induction chemotherapy in patients with newly diagnosed acute myeloid leukemia. Pemigatinib selectively inhibits FGFR (fibroblast growth factor receptor) activity, a receptor…
Phase: PHASE1 • Sponsor: OHSU Knight Cancer Institute • Aim: Disease control
Last updated Jul 16, 2026 00:00 UTC
-
New cocktail targets untreatable liver cancer
Disease control Recruiting nowThis phase I/II trial studies the side effects and how well nivolumab, fluorouracil, and interferon alpha 2b work for the treatment of fibrolamellar cancer (liver cell cancer) that cannot be removed by surgery (unresectable). Immunotherapy with monoclonal antibodies, such as nivo…
Phase: PHASE1, PHASE2 • Sponsor: M.D. Anderson Cancer Center • Aim: Disease control
Last updated Jun 27, 2026 09:11 UTC
-
Experimental combo aims to overcome drug resistance in metastatic cancers
Disease control Recruiting nowThe clinical trial is a phase 1, single-arm trial that will evaluate the safety of the investigational treatment on metastatic pancreatic cancer and metastatic breast cancer. The investigational treatment will involve 2 cycles of a combination of intravenous melphalan, BCNU, vita…
Phase: PHASE1 • Sponsor: General Oncology, Inc. • Aim: Disease control
Last updated Jun 27, 2026 09:00 UTC
-
Can a thymus gland protein shield dialysis patients from COVID-19?
Prevention CompletedThymalfasin (thymosin alpha 1 or Ta1), the active pharmaceutical ingredient in ZADAXIN® injection, is a 28-amino acid synthetic peptide, identical to natural Ta1 produced by the thymus gland. Ta1 is a biological response modifier which activates various cells of the immune system…
Phase: PHASE2 • Sponsor: William B. Ershler, MD • Aim: Prevention
Last updated Jun 27, 2026 12:23 UTC
-
Testosterone gel trial aims to beat cancer fatigue in older men
Symptom relief OngoingThis is a large randomized, double-blind, placebo-controlled trial to determine the efficacy of testosterone replacement on cancer-related fatigue in older men with solid or hematologic (blood) cancer who report fatigue and have low testosterone levels.
Phase: PHASE2 • Sponsor: Seattle Institute for Biomedical and Clinical Research • Aim: Symptom relief
Last updated Jul 08, 2026 00:00 UTC
-
New hope for rare leukemia: targeted pill shows promise in early trial
Disease control OngoingThis is an open-label, nonrandomized phase 2 trial to assess the efficacy of cobimetinib in RAS pathway activated CMML. All eligible patients will be treated daily with cobimetinib in 28-day cycles. Cobimetinib will be administered for three weeks followed by a one week break pr…
Phase: PHASE2 • Sponsor: University of Utah • Aim: Disease control
Last updated Jul 23, 2026 00:00 UTC
-
Brain pacemaker for Tourette's: 5-Year tracking study launches
Disease control Recruiting nowWithin an ongoing deep brain stimulation (DBS) program for Tourette syndrome (TS) at the Department of Neurology, Pitié-Salpêtrière Hospital, Paris/France, the investigator team plans to evaluate patients pre-operatively and then at one year intervals post-operatively until the 5…
Sponsor: Assistance Publique - Hôpitaux de Paris • Aim: Disease control
Last updated Jun 27, 2026 09:10 UTC
-
New drug combo shows promise in tough brain cancer
Disease control CompletedThis is an open-label, single-center Phase 0/2 study that will enroll up to 30 participants with newly diagnosed (N=12) and recurrent glioblastoma (N=18). The trial will be composed of a Phase 0 component (subdivided into Arm A, Arm B, and Arm C), and an Exploratory Phase 2 compo…
Phase: EARLY_PHASE1 • Sponsor: Nader Sanai • Aim: Disease control
Last updated Jun 27, 2026 12:33 UTC
-
Surgery before standard treatment may extend life in cervical cancer
Disease control Recruiting nowThis is an national, prospective, multicenter and randomized clinical study designed to determine if patients with stage IIICr of cervical cancer have longer PFS and/or OS with lymph node dissection before CCRT when compared to CCRT.
Phase: NA • Sponsor: Chongqing University Cancer Hospital • Aim: Disease control
Last updated Jun 26, 2026 12:34 UTC
-
Prenatal education may stop common virus that harms babies
Prevention CompletedThis study will evaluate whether a brief prenatal clinic-based cytomegalovirus (CMV) risk-reduction behavioral intervention will prevent maternal CMV infections during pregnancy in women.
Phase: NA • Sponsor: University of Alabama at Birmingham • Aim: Prevention
Last updated Jun 27, 2026 12:03 UTC
-
New drug shows promise for chronic itch in Long-Term trial
Symptom relief OngoingThe primary purpose of this study is to assess the long-term safety of nemolizumab (CD14152) in participants with prurigo nodularis (PN).
Phase: PHASE3 • Sponsor: Galderma R&D • Aim: Symptom relief
Last updated Jun 27, 2026 07:57 UTC
-
Blood test may unlock targeted cancer drug for more patients
Diagnosis OngoingA new drug, erdafitinib, became available for some patients with bladder cancer that has spread to other organs. To qualify, patients must have specific genetic changes in their tumors. Currently, doctors use tumor tissue samples to check for these genetic changes, but these samp…
Sponsor: Bernie Eigl • Aim: Diagnosis
Last updated Jun 27, 2026 08:04 UTC
-
New combo approach cuts heavy drinking and boosts HIV care in fishing communities
Disease control CompletedFisherfolk are a high risk population for HIV and are prioritized to receive antiretroviral treatment (ART) in Uganda, but risky alcohol use among fisherfolk is a barrier to HIV care engagement; multilevel factors influence alcohol use and poor access to HIV care in fishing villa…
Phase: NA • Sponsor: San Diego State University • Aim: Disease control
Last updated Jun 27, 2026 12:00 UTC
-
Quinoa diet shows promise for taming type 2 diabetes
Disease control Recruiting nowThe goal of this clinical trial is to explore whether quinoa diet can improve glycolipid metabolism and glucose fluctuations in patients with early-stage type 2 diabetes mellitus (T2DM) and observe its impact on islet β-cell function and insulin resistance in patients with early-…
Phase: NA • Sponsor: Qilu Hospital of Shandong University • Aim: Disease control
Last updated Jun 27, 2026 08:09 UTC
-
Proton beam therapy aims for safer prostate cancer treatment
Disease control OngoingThis is a single arm phase II study of image-guided pencil beam scanning proton SBRT (40Gy RBE in 5 fractions delivered every other day) for patients with low- and intermediate-risk prostate cancer. The primary aim is to assess GU/GI toxicity of proton SBRT and compare this to hi…
Phase: PHASE2 • Sponsor: The New York Proton Center • Aim: Disease control
Last updated Jun 27, 2026 12:07 UTC
-
New drug combo targets genetic weakness in advanced breast cancer
Disease control OngoingThe purpose of this study is to assess the safety and efficacy of alpelisib plus fulvestrant in men and postmenopausal women with hormone receptor (HR) positive, human epidermal growth factor 2 (HER2)-negative, advanced breast cancer harboring a PIK3CA mutation in Japan, whose di…
Phase: PHASE2 • Sponsor: Novartis Pharmaceuticals • Aim: Disease control
Last updated Jul 09, 2026 00:00 UTC
-
Could a simple skin zap spot melanoma sooner?
Diagnosis CompletedThe purpose of this study is to find out whether the Nevisense device can provide useful information about atypical moles to complement the usual assessments done during routine screening for melanoma. Assessing particpants' moles with the Nevisense device may help improve screen…
Sponsor: Memorial Sloan Kettering Cancer Center • Aim: Diagnosis
Last updated Jun 27, 2026 07:58 UTC
-
No-drill cavity treatment tested in kids: could it replace the dentist's drill?
Disease control CompletedTooth decay (dental caries) occurs when acids dissolve tooth structure. If not treated, cavities in primary teeth can progress quickly, leading to caries, infection and early tooth loss. These problems may affect chewing, speech, nutrition, and overall health. In Albania and many…
Phase: NA • Sponsor: Beaty Dent • Aim: Disease control
Last updated Jun 26, 2026 13:19 UTC
-
Blood test may end need for live wasp stings to check allergy treatment
Diagnosis Recruiting nowInsect venom allergy is the major cause for severe allergic reactions in Europe. Wasps and honeybees are responsible for the majority of these allergic reactions. Symptoms range from generalized skin symptoms (wheals, swellings) to respiratory or cardiovascular problems such as a…
Phase: NA • Sponsor: Medical University of Graz • Aim: Diagnosis
Last updated Jun 27, 2026 07:52 UTC
-
Alzheimer's Tau-Targeting antibody trial halted midway
Disease control TerminatedThe primary purpose of this study is to evaluate the effect of JNJ-63733657 versus placebo on clinical decline as measured by the Integrated Alzheimer's Disease Rating Scale (iADRS), a composite of cognition and function.
Phase: PHASE2 • Sponsor: Janssen Research & Development, LLC • Aim: Disease control
Last updated Jun 27, 2026 12:03 UTC